Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Benecol

This article was originally published in The Tan Sheet

Executive Summary

McNeil Consumer Healthcare phasing out plant stanol ester-containing bars, saying consumers have "indicated a preference" for the brand's cholesterol-lowering spreads. Benecol SoftGel supplements, which launched in late 1999, are available in limited distribution; the J&J subsidiary discontinued the brand's salad dressings earlier this year (1"The Tan Sheet" May 1, In Brief). Single-serve packets of Benecol spread are now available solely through McNeil's Healthy Hospitals program, in which patients admitted for a cardiac event are given, at mealtime, Benecol and information about cholesterol. In food/drug/mass, Benecol and Lipton's Take Control continue to lag behind other margarines/spreads in the $1.29 bil. category, with each holding a 2.3% dollar share for the 52 weeks ended May 21, according to IRI

You may also be interested in...



Benecol, Take Control Marketing Highlight Approved CHD Health Claims

McNeil Consumer Healthcare's Benecol spread will soon be carrying labeling stating it can reduce the risk of coronary heart disease, the company said. The new labeling follows FDA's Sept. 8 approval of McNeil's health claim petition.

Benecol, Take Control Marketing Highlight Approved CHD Health Claims

McNeil Consumer Healthcare's Benecol spread will soon be carrying labeling stating it can reduce the risk of coronary heart disease, the company said. The new labeling follows FDA's Sept. 8 approval of McNeil's health claim petition.

Benecol, Take Control Marketing Highlight Approved CHD Health Claims

McNeil Consumer Healthcare's Benecol spread will soon be carrying labeling stating it can reduce the risk of coronary heart disease, the company said. The new labeling follows FDA's Sept. 8 approval of McNeil's health claim petition.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091477

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel